{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:43:49Z","timestamp":1768718629640,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12664-018-0842-0","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T20:12:02Z","timestamp":1524859922000},"page":"141-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India"],"prefix":"10.1007","volume":"37","author":[{"given":"Ravi","family":"Daswani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6680-7227","authenticated-orcid":false,"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrihari Anil","family":"Anikhindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,28]]},"reference":[{"key":"842_CR1","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758\u201369.","journal-title":"N Engl J Med"},{"key":"842_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","volume":"57","author":"European Association for the Study of Liver","year":"2012","unstructured":"European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012;57:399\u2013420.","journal-title":"J Hepatol"},{"key":"842_CR3","doi-asserted-by":"crossref","unstructured":"Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology. 1997;25:108\u201311.","DOI":"10.1002\/hep.510250120"},{"key":"842_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0016-5085(87)90861-4","volume":"92","author":"H Orrego","year":"1987","unstructured":"Orrego H, Blake JE, Blendis LM, Medline A. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology. 1987;92:208\u201314.","journal-title":"Gastroenterology"},{"key":"842_CR5","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3748\/wjg.v16.i19.2435","volume":"16","author":"CH Yu","year":"2010","unstructured":"Yu CH, Xu CF, Ye H, Li L, Li YM. Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials. World J Gastroenterol. 2010;16:2435\u20139.","journal-title":"World J Gastroenterol"},{"key":"842_CR6","first-page":"CD001511","volume":"11","author":"CS Pavlov","year":"2017","unstructured":"Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C. Glucocorticosteroids for people with alcoholic hepatitis. Cochrane Database Syst Rev. 2017;11:CD001511.","journal-title":"Cochrane Database Syst Rev"},{"key":"842_CR7","doi-asserted-by":"crossref","unstructured":"Mathurin P, Duchatelle V, Ramond MJ, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology. 1996;110:1847\u201353.","DOI":"10.1053\/gast.1996.v110.pm8964410"},{"key":"842_CR8","doi-asserted-by":"crossref","unstructured":"Papastergiou V, Tsochatzis EA, Pieri G, et al. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther. 2014;39:721\u201332.","DOI":"10.1111\/apt.12654"},{"key":"842_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2008.10.024","volume":"50","author":"P Sharma","year":"2009","unstructured":"Sharma P, Kumar A, Sharma BC, Sarin SK. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial. J Hepatol. 2009;50:584\u201391.","journal-title":"J Hepatol"},{"key":"842_CR10","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3748\/wjg.15.1613","volume":"15","author":"BK De","year":"2009","unstructured":"De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol. 2009;15:1613\u20139.","journal-title":"World J Gastroenterol"},{"key":"842_CR11","doi-asserted-by":"crossref","unstructured":"Sidhu SS, Goyal O, Singla P, et al. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial). Dig Dis Sci. 2012;57:1664\u201371.","DOI":"10.1007\/s10620-012-2097-4"},{"key":"842_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/jgh.12400","volume":"29","author":"M Kadian","year":"2014","unstructured":"Kadian M, Kakkar R, Dhar M, Kaushik RM. Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis. J Gastroenterol Hepatol. 2014;29:581\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"842_CR13","doi-asserted-by":"crossref","unstructured":"Forrest E, Mellor J, Stanton L, et al. Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials. 2013;14:262.","DOI":"10.1186\/1745-6215-14-262"},{"key":"842_CR14","doi-asserted-by":"crossref","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ. Practice guideline Committee of the American Association for the study of liver diseases, practice parameters Committee of the American College of gastroenterology. Alcoholic liver disease. Hepatology. 2010;51:307\u201328.","DOI":"10.1002\/hep.23258"},{"key":"842_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s10620-015-3921-4","volume":"61","author":"R Maiwall","year":"2016","unstructured":"Maiwall R, Chandel SS, Wani Z, Kumar S, Sarin SK. SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis. Dig Dis Sci. 2016;61:920\u20139.","journal-title":"Dig Dis Sci"},{"key":"842_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12072-017-9790-5","volume":"11","author":"SS Sidhu","year":"2017","unstructured":"Sidhu SS, Goyal O, Kishore H, Sidhu S. New paradigms in management of alcoholic hepatitis: a review. Hepatol Int. 2017;11:255\u201367.","journal-title":"Hepatol Int"},{"key":"842_CR17","doi-asserted-by":"crossref","unstructured":"Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619\u201328.","DOI":"10.1056\/NEJMoa1412278"},{"key":"842_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.4103\/2141-9248.141562","volume":"4","author":"B De","year":"2014","unstructured":"De B, Mandal S, Sau D, et al. Pentoxifylline plus prednisolone versus pentoxifylline only for severe alcoholic hepatitis: a randomized controlled clinical trial. Ann Med Health Sci Res. 2014;4:810\u20136.","journal-title":"Ann Med Health Sci Res"},{"key":"842_CR19","doi-asserted-by":"crossref","unstructured":"Lee YS, Kim HJ, Kim JH, et al. Treatment of severe alcoholic hepatitis with corticosteroid, pentoxifylline, or dual therapy: a systematic review and meta-analysis. J Clin Gastroenterol. 2017;51:364\u201377.","DOI":"10.1097\/MCG.0000000000000674"},{"key":"842_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jceh.2014.02.006","volume":"4","author":"SK Goyal","year":"2014","unstructured":"Goyal SK, Dixit VK, Jain AK, Mohapatra PK, Ghosh JK. Assessment of the model for end-stage liver disease (MELD) score in predicting prognosis of patients with alcoholic hepatitis. J Clin Exp Hepatol. 2014;4:19\u201324.","journal-title":"J Clin Exp Hepatol"},{"key":"842_CR21","doi-asserted-by":"crossref","unstructured":"Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353\u20138.","DOI":"10.1002\/hep.20503"},{"key":"842_CR22","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3748\/wjg.v12.i25.4020","volume":"12","author":"AS Soultati","year":"2006","unstructured":"Soultati AS, Dourakis SP, Alexopoulou A, Deutsch M, Vasilieva L, Archimandritis AJ. Predicting utility of a model for end stage liver disease in alcoholic liver disease. World J Gastroenterol. 2006;12:4020\u20135.","journal-title":"World J Gastroenterol"},{"key":"842_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/1751-2980.12074","volume":"14","author":"A Duseja","year":"2013","unstructured":"Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis. 2013;14:484\u201390.","journal-title":"J Dig Dis"},{"key":"842_CR24","doi-asserted-by":"crossref","unstructured":"Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365:1790\u2013800.","DOI":"10.1056\/NEJMoa1105703"},{"key":"842_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3109\/00365521.2011.587200","volume":"46","author":"TD Sandahl","year":"2011","unstructured":"Sandahl TD, Jepsen P, Ott P, Vilstrup H. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol. 2011;46:1127\u201332.","journal-title":"Scand J Gastroenterol"},{"key":"842_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/apt.12414","volume":"38","author":"H Lafferty","year":"2013","unstructured":"Lafferty H, Stanley AJ, Forrest EH. The management of alcoholic hepatitis: a prospective comparison of scoring systems. Aliment Pharmacol Ther. 2013;38:603\u201310.","journal-title":"Aliment Pharmacol Ther"},{"key":"842_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4254\/wjh.v3.i5.118","volume":"3","author":"G Basra","year":"2011","unstructured":"Basra G, Basra S, Parupudi S. Symptoms and signs of acute alcoholic hepatitis. World J Hepatol. 2011;3:118\u201320.","journal-title":"World J Hepatol"},{"key":"842_CR28","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/ajg.2014.154","volume":"109","author":"V Singh","year":"2014","unstructured":"Singh V, Sharma AK, Narasimhan RL, Bhalla A, Sharma N, Sharma R. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am J Gastroenterol. 2014;109:1417\u201323.","journal-title":"Am J Gastroenterol"},{"key":"842_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/MEG.0000000000000801","volume":"29","author":"R Prajapati","year":"2017","unstructured":"Prajapati R, Arora A, Sharma P, Bansal N, Singla V, Kumar A. Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial. Eur J Gastroenterol Hepatol. 2017;29:448\u201355.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"842_CR30","doi-asserted-by":"crossref","unstructured":"Philips CA, Pande A, Shasthry SM, et al. Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study. Clin Gastroenterol Hepatol. 2017;15:600\u20132.","DOI":"10.1016\/j.cgh.2016.10.029"},{"key":"842_CR31","unstructured":"Daswani R, Kumar A, Sharma P, Singla V, Bansal N, Arora A. Role of liver transplantation in severe alcoholic hepatitis. Clin Mol Hepatol. 2018; 2018;24:43\u201350."}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-018-0842-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-018-0842-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-018-0842-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T19:13:40Z","timestamp":1556392420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-018-0842-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1007\/s12664-018-0842-0","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"8 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"RD, AK, SAA, PS, VS, NB, and AA declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in a manner to conform with the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on .The Ethics Committee of the hospital approved the study, and the study conformed to the Helsinki declaration of 1975 as revised in 1983.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}